We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
-14.96%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$259B
AUM Growth
-$50.1B
Cap. Flow
-$2.12B
Cap. Flow %
-0.82%
Top 10 Hldgs %
21.65%
Holding
3,641
New
264
Increased
1,460
Reduced
1,409
Closed
415

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$499M
2
UNH icon
UnitedHealth
UNH
+$463M
3
ORCL icon
Oracle
ORCL
+$392M
4
ELV icon
Elevance Health
ELV
+$387M
5
PEP icon
PepsiCo
PEP
+$343M

Top Sells

Rank Stock Value
1
CSCO icon
Cisco
CSCO
+$321M
2
BIDU icon
Baidu
BIDU
+$269M
3
NVDA icon
NVIDIA
NVDA
+$262M
4
ABBV icon
AbbVie
ABBV
+$260M
5
GM icon
General Motors
GM
+$248M

Sector Composition

Rank Sector Weight
1 Technology 23.57%
2 Healthcare 13.99%
3 Financials 12.35%
4 Consumer Discretionary 10.52%
5 Industrials 8.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
USX
3551
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
-143,255
Closed -$667K
EVLO
3552
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
-4,809
Closed -$310K
ONCR
3553
DELISTED
Oncorus, Inc.
ONCR
-96,208
Closed -$159K
FNCH
3554
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
-400
Closed -$64K
TCRR
3555
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
-169,674
Closed -$467K
SGTX
3556
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
-1,740
Closed -$31K
SDIG
3557
DELISTED
Stronghold Digital Mining, Inc. Class A Common Stock
SDIG
-1,119
Closed -$65K
CDAK
3558
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
-37,184
Closed -$234K
DCT
3559
PUT
DELISTED
Duck Creek Technologies, Inc. Common Stock
DCT
-103,000
Closed -$2K
ISO
3560
DELISTED
IsoPlexis Corporation Common Stock
ISO
-12,874
Closed -$44K
RAAS
3561
DELISTED
Cloopen Group Holding Limited American Depositary Shares (each representing six (6) Class A Ordinary Shares)
RAAS
-17,333
Closed -$89K
SFT
3562
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
-33,661
Closed -$902K
RUBY
3563
DELISTED
Rubius Therapeutics, Inc
RUBY
-184,772
Closed -$1.02M
ATNX
3564
DELISTED
Athenex, Inc. Common Stock
ATNX
-14,383
Closed -$3.48M
HYRE
3565
DELISTED
HyreCar Inc. Common Stock
HYRE
-55,388
Closed -$154K
IVC
3566
DELISTED
Invacare Corporation
IVC
-323,388
Closed -$515K
OYST
3567
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
-107,352
Closed -$1.25M
DS
3568
DELISTED
Drive Shack Inc.
DS
-1,002,554
Closed -$1.3M
CLVS
3569
DELISTED
Clovis Oncology, Inc.
CLVS
-549,293
Closed -$32.4M
NH
3570
DELISTED
NantHealth, Inc
NH
-5,401
Closed -$65K
LOTZ
3571
DELISTED
CarLotz, Inc. Class A Common Stock
LOTZ
-280,109
Closed -$445K
AKUS
3572
DELISTED
Akouos Inc
AKUS
-93,112
Closed -$426K
QTNT
3573
DELISTED
Quotient Limited Ordinary Shares
QTNT
-5,808
Closed -$232K
ZY
3574
DELISTED
Zymergen Inc. Common Stock
ZY
-61,233
Closed -$2.13M
RMO
3575
DELISTED
Romeo Power, Inc.
RMO
-415,342
Closed -$677K

Similar funds

Nuveen's Q2 2022 Portfolio in Review

As of Q2 2022, Nuveen held 3,641 positions worth $259B, down 16% from $309B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Nuveen's Q2 2022 filing shows 264 new, 1,460 increased, 1,409 reduced and 415 closed positions. Its largest new stake was Coinbase: 292,590 shares worth $13.8M. The largest sale was Cisco, an estimated $321M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

  • Nuveen's largest Q2 2022 buy was Coinbase: 292,590 shares worth $13.8M.
  • Nuveen added most to Linde in Q2 2022, an estimated $499M increase.
  • Nuveen's biggest Q2 2022 reduction was Cisco, cutting an estimated $321M.
  • Nuveen fully exited Cerner Corp in Q2 2022, selling an estimated $135M.
  • Nuveen's ten largest holdings make up 22% of its $259B portfolio in Q2 2022.
  • Nuveen opened 264 new positions and closed 415 in Q2 2022.
  • Nuveen's portfolio value fell 16% quarter-over-quarter to $259B.

Based on Nuveen's 13F filing for Q2 2022, filed 15 Aug 2022.